Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in J apanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled …

M Furue, Y Kitahara, H Akama, S Hojo… - The Journal of …, 2014 - Wiley Online Library
The safety and efficacy of topical E6005, a novel phosphodiesterase 4 inhibitor, in Japanese
adults with atopic dermatitis were evaluated. A total of 78 patients were randomized to …
被引用次数：81 相关文章

[引用][C] Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle …

M FURUE, Y KITAHARA, H AKAMA, S HOJO… - Journal of …, 2014 - jglobal.jst.go.jp
Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult
patients with atopic dermatitis: Results of a randomized, vehicle-controlled, multicenter …

[引用][C] Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle …

M Furue, Y Kitahara, H Akama, S Hojo… - The Journal of …, 2014 - cir.nii.ac.jp
Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult
patients with atopic dermatitis: Results of a randomized, vehicle-controlled, multicenter clinical …

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled …

M Furue, Y Kitahara, H Akama, S Hojo… - The Journal of …, 2014 - europepmc.org
The safety and efficacy of topical E6005, a novel phosphodiesterase 4 inhibitor, in Japanese
adults with atopic dermatitis were evaluated. A total of 78 patients were randomized to …

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled …

M Furue, Y Kitahara, H Akama, S Hojo, N Hayashi… - 2014 - pubmed.ncbi.nlm.nih.gov
The safety and efficacy of topical E6005, a novel phosphodiesterase 4 inhibitor, in Japanese
adults with atopic dermatitis were evaluated. A total of 78 patients were randomized to …

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle-controlled …

M Furue, Y Kitahara, H Akama… - Journal of …, 2014 - kyushu-u.elsevierpure.com
The safety and efficacy of topical E6005, a novel phosphodiesterase 4 inhibitor, in Japanese
adults with atopic dermatitis were evaluated. A total of 78 patients were randomized to …

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in J apanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled …

M Furue, Y Kitahara, H Akama, S Hojo… - The Journal of …, 2014 - infona.pl
The safety and efficacy of topical E6005, a novel phosphodiesterase 4 inhibitor, in Japanese
adults with atopic dermatitis were evaluated. A total of 78 patients were randomized to …